Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 12:52 AM
Ignite Modification Date:
2025-12-25 @ 11:07 PM
NCT ID:
NCT05269667
Pre Assignment Details:
A total of 4 participants with neuromyelitis optica spectrum disorder (NMOSD) were enrolled in 'Cohort 2: Inadequate Responders to Previous Rituximab (RTX) Treatment' to receive satralizumab. No participants were enrolled in 'Cohort 1: Treatment-naïve Participants' due to early study termination.
Recruitment Details:
Participants took part in this study at 3 investigative sites in 3 countries.
Study:
NCT05269667
Study Brief:
Results Section:
NCT05269667